// STATE LEGISLATION TRACKER

Florida SB 1418: Testing of Cosmetics on Animals

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Failed

State: Florida
Bill: SB 1418
Session: 2026
Filed: 2026-01-08
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Florida SB1418 was about banning animal testing in cosmetics manufacturing and sales, with inspections and penalties for cosmetic manufacturers. Based on the title, subject, and status, it has no direct peptide-ecosystem relevance for compounded peptides, prescribing, telehealth, clinician scope, FDA 503A/503B compounding, controlled substances, or PDMP rules.

Key Points

No apparent effect on access to compounded peptides
No change to off-label prescribing or telehealth care
No NP or naturopathic scope-of-practice change
No FDA 503A or 503B compounding provision identified
No controlled-substance or PDMP impact identified

What to Watch For

Note The bill appears limited to cosmetics animal-testing rules, not drugs or compounded medications.

Note It died in committee, so it is not moving forward in the 2026 session.

Where the Bill Stands

The bill died in the Senate Regulated Industries committee on March 13, 2026.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws